SCHEMBL2519157

SCHEMBL2519157

N#C/C(=N/O)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL425064 1.00
SCHEMBL425065 1.00
SCHEMBL3067270 0.77
SCHEMBL3067267 0.77
SCHEMBL3067274 0.77
SCHEMBL2723133 0.74
Potassium Ion SCHEMBL18640391 0.74
SCHEMBL9464704 0.74
SCHEMBL9464708 0.74
Potassium Ion SCHEMBL18640390 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250326798-A1 Synthetic Process for Production of Modified GCC Receptor Agonists IRONWOOD PHARMACEUTICALS INC (US) 2025-10-23 US claimed
EP-4436980-A1 SYNTHETIC PROCESS FOR PRODUCTION OF MODIFIED GCC RECEPTOR AGONISTS Ironwood Pharmaceuticals, Inc. (US) 2024-10-02 EP claimed
EP-3862431-B1 METHOD FOR PRODUCING HAIRPIN SINGLE-STRAND RNA MOLECULES TORAY INDUSTRIES (JP) 2024-06-26 EP claimed
EP-3781586-B1 A METHOD FOR PRODUCTION OF HIGH PURITY ICATIBANT FRESENIUS KABI IPSUM S R L (IT) 2024-04-17 EP claimed
EP-3899532-B1 A LABELLING METHOD TO DISTINGUISH ISOBARIC AMINO ACIDS AND AMINO ACID COMBINATIONS RAPID NOVOR INC (CA) 2024-02-14 EP claimed
EP-4201951-B1 METHOD FOR PEPTIDE SYNTHESIS BACHEM HOLDING AG (CH) 2023-11-22 EP claimed
EP-4240740-A1 PROCESS FOR PREPARING HETEROCYCLIC METHANONE COMPOUNDS AND AZA-BICYCLO INTERMEDIATES THEREOF Actinogen Medical Limited (AU) 2023-09-13 EP claimed
WO-2023097207-A1 SYNTHETIC PROCESS FOR PRODUCTION OF MODIFIED GCC RECEPTOR AGONISTS IRONWOOD PHARMACEUTICALS, INC. (US) 2023-06-01 WO claimed
WO-2022094668-A1 PROCESS FOR PREPARING HETEROCYCLIC METHANONE COMPOUNDS AND AZA-BICYCLO INTERMEDIATES THEREOF Actinogen Medical Limited (AU) 2022-05-12 WO claimed
EP-3924330-A1 METHOD OF PREPARING A DON PRODRUG FROM L-GLUTAMIC ACID Dracen Pharmaceuticals, Inc. (US) 2021-12-22 EP claimed
WO-2018034901-A1 N-CARBOXYANHYDRIDE-BASED-SCALE SYNTHESIS OF ELAMIPRETIDE STEALTH BIOTHERAPEUTICS (US) 2018-02-22 WO claimed
EP-2694531-B1 METHODS FOR MANUFACTURING AN ANTIFUNGAL AGENT XELLIA PHARMACEUTICALS APS (DK) 2016-09-14 EP claimed
US-20140296144-A1 PROCESS FOR THE PREPARATION OF OCTREOTIDE ACETATE MYLAN LABORATORIES LIMITED (IN) 2014-10-02 US claimed
US-20130060004-A1 Novel Process For The Preparation Of Leuprolide And Its Pharmaceutically Acceptable Salts Thereof MYLAN LABORATORIES LIMITED (IN) 2013-03-07 US claimed
EP-0294668-B1 (2-CYANO-2-OXIMINOACETYL)-AMINO ACID DERIVATIVES BAYER AG (DE) 1993-04-07 EP claimed
EP-0294667-B1 (2-CYANO-2-OXIMINOACETYL)-AMINO ACID DERIVATIVES BAYER AG (DE) 1993-03-17 EP claimed
EP-0257294-B1 E/Z-ISOMERIC MIXTURES AND PURE Z-ISOMERS OF N-ALPHA-(2-CYANO-2-ALKOXYIMINOACETYL) AMINO-ACID DERIVATIVES AND LIKE PEPTIDES BAYER AG (DE) 1990-09-12 EP claimed
EP-0294667-A2 (2-cyano-2-oximinoacetyl)-amino acid derivatives BAYER AG (DE) 1988-12-14 EP claimed
EP-0257294-A1 E/Z-isomeric mixtures and pure Z-isomers of N-alpha-(2-cyano-2-alkoxyiminoacetyl) amino-acid derivatives and like peptides BAYER AG (DE) 1988-03-02 EP claimed
EP-0087048-B1 SUBSTITUTED OXIMINOACETANILIDES, METHOD FOR THEIR PREPARATION AS WELL AS THEIR USE AS PESTICIDES BAYER AG (DE) 1985-04-17 EP claimed